COVID-19: Good intentions do not guarantee vaccines and treatments for everyone
Sovereignty: the best medicine against COVID-19
Compulsory licenses to guarantee access to medical technologies
Argentina: Fundación GEP opposed Gilead´s patent application on remdesivir
COVID19- South America: Gilead block access to coronavirus treatment for 440 million people
RedLAM in Geneva: A week of actions against the Corporate Power and to reclaim Peoples Sovereignty 
Fundación GEP filed patent opposition on Hepatitis C treatment
Argentina: elimination of the Ministry of Health threatens PLHIV lives
Argentina: Stockouts of ARVs threatens continuation of HIV treatments
Hepatitis C: In Argentina INPI rejected a key patent on Sofosbuvir
The power of communities against monopolies
Gilead forced to withdraw Truvada® patent application in Argentina
GEP filed new opposition to patent request for Hepatitis C drug in Argentina
International Congress on Access to Medicines and Human Rights’ Full Schedule
International Congress on Access to Medicines, Medical Technologies and Human Rights